FreeAgent f68aadb982a203bdbbf9ad4edfad339384d41aa6 false No description of principal activity 19 February 2025 28 February 2026 162640232025-02-192026-02-28 16264023uk-bus:Director12025-02-192026-02-28 16264023uk-bus:AuditExempt-NoAccountantsReport2025-02-192026-02-28 16264023uk-bus:Micro-entities2025-02-192026-02-28 16264023uk-bus:FullAccounts2025-02-192026-02-28 16264023uk-bus:PrivateLimitedCompanyLtd2025-02-192026-02-28 16264023uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2025-02-192026-02-28 162640232025-02-19 162640232026-02-28 16264023uk-core:CurrentFinancialInstruments2026-02-28 16264023uk-core:Non-currentFinancialInstruments2026-02-28 iso4217:GBP xbrli:pure

Myab Pharma Limited

Unaudited financial statements for the period from 19 February 2025 to 28 February 2026


Company information

Myab Pharma Limited is a private company limited by shares, registered in England and Wales, registered number 16264023.

The company's registered office is: Suite G04 1 Quality Court, Chancery Lane, London, WC2A 1HR, United Kingdom.

Balance Sheet

as at 28 February 2026

13 months to
28 Feb 26
£ £
Current assets 507.42
Creditors: amounts falling due within one year (96.14)
Net current assets / (liabilities) 411.28
Total assets less current liabilities 411.28
Net assets 411.28
Capital and reserves 411.28

For the period from 19 February 2025 to 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Abdullahi Marfat
16 June 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 0.